Federal Circuit Affirms Ruling On Prilosec Process
An appeals court on Monday affirmed a district court's ruling that generic maker Andrx Pharmaceuticals Inc. infringed on claims of AstraZeneca LP's patent for its gastric acid-inhibiting drug, Prilosec, and affirmed...To view the full article, register now.
Already a subscriber? Click here to view full article